By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Innovus Pharma 

4275 Executive Square
Suite 200
La Jolla  California  92037  U.S.A.
Phone: 858-964-5123 Fax: 858-964-2301



Company News
Innovus Pharma Announces The Approval To Commercialize Zestra In South Korea Through Its Partner J&H Co. LTD 2/3/2017 7:59:00 AM
Innovus Pharma Expands Its Executive Management Team With The Addition Of Randy Berholtz As Its Executive Vice President, Corporate Development And General Counsel 1/9/2017 11:34:05 AM
Innovus Pharma Strengthens Its Respiratory Franchise With The In-Licensing Of Lertal Tablets, A Clinically Proven Supplement For The Relief Of Allergic Rhinitis Symptoms From NTC For The United States And Canada 12/19/2016 10:14:31 AM
Innovus Pharma Launches Its Clinically Proven Urivarx Product For Bladder Health Through Its Beyond Human Sales And Marketing Platform In The United States 12/1/2016 9:02:18 AM
Innovus Pharma Signs $2 Million A Year Exclusive License And Distribution Agreement With J&H Co. LTD For Zestra For Female Sexual Arousal In South Korea 11/29/2016 10:52:45 AM
Innovus Pharma Launches Zestra Multi-Dose Form For Female Sexual Arousal In The U.S. 11/21/2016 12:34:16 PM
Innovus Pharma Reports Record Quarterly Revenues For The Third Quarter Of 2016, Increasing 947% To $1.9 Million, And Record Nine Months Ended September 2016 Revenues, Increasing 463% To $3.1 Million 11/11/2016 12:59:42 PM
Innovus Pharma Signs Exclusive License And Distribution Agreement With Elis Pharmaceuticals Limited For Zestra In Lebanon 11/8/2016 10:23:01 AM
Innovus Pharma To Release Third Quarter 2016 Financial Results And Provide Corporate Update On Thursday, November 10, 2016 11/7/2016 11:14:00 AM
Innovus Pharma Licenses Urox Formulation Targeting $3+ Billion Markets -- 10/21/2016 7:59:37 AM